:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Lyu Wang, Yun‐Yang Deng, Tsung Yu, Xiang‐Qian Lao, Martin C. S. Wong
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Obesity
Online Access:	https://onlinelibrary.wiley.com/doi/10.1002/oby.24062
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association of body roundness index with cardiovascular disease and all‐cause mortality among Chinese adults
by: Hong Lin, et al.
Published: (2025)

Association of metabolic score for visceral fat with all‐cause mortality, cardiovascular mortality, and cancer mortality: A prospective cohort study
by: Shanshan Jia, et al.
Published: (2024)

Association of cumulative exposure to cholesterol, high‐density lipoprotein, and glucose index with the risk of cardiovascular disease and all‐cause mortality: A longitudinal cohort study
by: Ruobing Tian, et al.
Published: (2025)

Cardiovascular autonomic dysfunction precedes cardiovascular disease and all‐cause mortality: 11‐year follow‐up in the ADDITION ‐ PRO study
by: Jonas R. Schaarup, et al.
Published: (2025)

Associations of relative fat mass and BMI with all‐cause mortality: Confounding effect of muscle mass
by: Navin Suthahar, et al.
Published: (2024)

Biological aging mediates the associations of metabolic score for insulin resistance with all‐cause and cardiovascular disease mortality among US adults: A nationwide cohort study
by: Xiaoxuan Li, et al.
Published: (2024)

Impact of time in tight range on all‐cause and cardiovascular mortality in type 2 diabetes: A prospective cohort study
by: Jinghao Cai, et al.
Published: (2025)

Associations between Chinese visceral adiposity index and risks of all‐cause and cause‐specific mortality: A population‐based cohort study
by: Xiaoyan Wu, et al.
Published: (2024)

Longitudinal exposure to non‐ HDL ‐C and cardiovascular events, all‐cause mortality in type 2 diabetes: A post hoc analysis of the ACCORD trial
by: Yueyue Wang, et al.
Published: (2026)

Long‐term all‐cause mortality of metabolic‐dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study
by: Jaycie Koh, et al.
Published: (2024)

Risk acceleration by gout on major adverse cardiovascular events and all‐cause death in patients with diabetes and chronic kidney disease
by: Da Young Lee, et al.
Published: (2025)

Sex‐specific associations between haemoglobin glycation index and the risk of cardiovascular and all‐cause mortality in individuals with pre‐diabetes and diabetes: A large prospective cohort study
by: Jingqi Yang, et al.
Published: (2024)

Low serum 1,5‐anhydroglucitol is associated with increased risk of all‐cause and cardiovascular mortality in type 2 diabetes: A real‐world cohort study
by: Jiaying Ni, et al.
Published: (2025)

Estimating the risk of cardiovascular outcomes and all‐cause mortality in individuals with type 2 diabetes: Validation of the UKPDS outcomes model using TECOS and EXSCEL data
by: Ruth L. Coleman, et al.
Published: (2025)

Lack of evidence for obesity paradox in patients with cardiovascular disease: A UK BioBank cohort study
by: Wenhao Yu, et al.
Published: (2025)

Metabolic bariatric surgery is associated with reduced adverse hepatic and extrahepatic outcomes, and lower all‐cause mortality, in patients with steatotic liver disease
by: Weronika Stupalkowska, et al.
Published: (2025)

Continuous glucose monitoring and all‐cause mortality in insulin‐using population with diabetes and cognitive impairment
by: Pareeta Kotecha, et al.
Published: (2024)

Brain structure differences in pediatric obesity: cause or consequence?
by: Susan Carnell
Published: (2024)

Does deciding not to participate in a lifestyle intervention for children with obesity affect the long‐term weight change?
by: Rasmus M. Jørgensen, et al.
Published: (2025)

Association of gestational diabetes with long‐term risk of premature mortality, and cardiovascular outcomes and risk factors: A retrospective cohort analysis in the UK Biobank
by: Moscho Michalopoulou, et al.
Published: (2024)

Graded association of muscle strength with all‐cause and cause‐specific mortality in older adults with diabetes: Prospective cohort study across 28 countries
by: Lars Louis Andersen, et al.
Published: (2024)

Association of GLP1 ‐receptor agonist use with liver disease progression, major cardiovascular events, and mortality in people with hepatic steatosis and diabetes
by: Suleiman Al Ashi, et al.
Published: (2025)

Association of obesity or metabolic syndrome with various allergic diseases: An overview of reviews
by: Yasutaka Kuniyoshi, et al.
Published: (2024)

Modification of the association between obesity phenotypes and cardiovascular disease by social determinants of health: A prospective cohort study
by: Qiujin Huang, et al.
Published: (2026)

Unraveling the obesity paradox in polytrauma patients: survival benefit specifically in individuals with obesity class I
by: Hui‐Tzung Luh, et al.
Published: (2025)

Trends in educational inequalities in obesity‐attributable mortality in England and Wales, Finland, and Italy
by: Fanny Janssen, et al.
Published: (2025)

Correction to “Lack of evidence for obesity paradox in patients with cardiovascular disease: A UK BioBank cohort study”
Published: (2025)

Disruption of Ephb1 causes reduced hypothalamic CRH and TRH expression and obesity in mice
by: Simin Xie, et al.
Published: (2025)

Trends in mortality and hospitalisations for cardiovascular, kidney and liver disease in people with type 2 diabetes in England, 2009–2019
by: Naomi Holman, et al.
Published: (2025)

BMI and mortality in critically ill patients with COVID‐19: another brick in the wall of the obesity paradox
by: Amanda Vilaverde Perez, et al.
Published: (2024)

Association of overweight/obesity and overweight/obesity‐related metabolic dysfunction‐associated steatotic liver disease in young adults with coronary artery calcification later in life
by: Jia‐Jie Wang, et al.
Published: (2024)

Glucagon‐like peptide‐1 receptor agonists lower risk of cardiovascular and non‐cardiovascular mortality: A meta‐analysis of eleven cardiovascular outcome trials
by: Yu Mi Kang, et al.
Published: (2025)

Association between the changes in the estimated glucose disposal rate and new‐onset cardiovascular disease in middle‐aged and elderly individuals: A nationwide prospective cohort study in China
by: Lunqing Yan, et al.
Published: (2025)

Prevalence of obesity and cardiovascular disease in adults with type 2 diabetes and use of diabetes medication in Germany: A claims data study
by: Nora Hennies, et al.
Published: (2024)

Association of normal range of urinary albumin‐to‐creatinine ratio with all‐cause mortality among diabetic adults with preserved kidney function: National Health and Nutrition Examination Survey ( NHANES ) 2003–2018
by: Xiaoxia Pang, et al.
Published: (2025)

The critical role of abdominal obesity as a crucial cardiovascular risk factor
by: Salvatore Corrao, et al.
Published: (2024)

Metabolomics: Implication in cardiovascular research and diseases
by: Amir Ajoolabady, et al.
Published: (2024)

Risk factor control and incident cardiovascular disease in patients with diabetes: Sex‐specific relations
by: Xuan Wang, et al.
Published: (2024)

Ceramide‐based risk score CERT‐1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: A prospective cohort study
by: Alessandro Mantovani, et al.
Published: (2024)

Contribution of genetic and environmental factors to obesity indices and their overlap
by: Alireza Ani, et al.
Published: (2026)